About Peijia
Corporate Overview
Introduction of Achieva Medical
Milestones
Management Team
Awards and Recognitions
Social Responsibility
Diseases and Solutions
Valvular Heart Diseases
Stroke
Product Center
TAVR
Neurointerventional Procedural Products
Investor Relations
Corporate Information
Prospectus
Financial Reports
Announcements and Circulars
Presentation Materials
Corporate Governance
Investor Enquiries
News Center
Careers
Contact Us
简
繁
About Peijia
Corporate Overview
Introduction of Achieva Medical
Milestones
Management Team
Awards and Recognitions
Social Responsibility
Diseases and Solutions
Valvular Heart Diseases
Stroke
Product Center
TAVR
Neurointerventional Procedural Products
Investor Relations
Corporate Information
Prospectus
Financial Reports
Announcements and Circulars
Presentation Materials
Corporate Governance
Investor Enquiries
News Center
Careers
Contact Us
简
繁
About Peijia
Corporate Overview
Introduction of Achieva Medical
Milestones
Management Team
Awards and Recognitions
Social Responsibility
Diseases and Solutions
Valvular Heart Diseases
Stroke
Product Center
TAVR
Neurointerventional Procedural Products
Investor Relations
Corporate Information
Prospectus
Financial Reports
Announcements and Circulars
Presentation Materials
Corporate Governance
Investor Enquiries
News Center
Careers
Contact Us
Presentation Materials
2022/04/01
Peijia Medical’s 2021 Annual Results Presentation Materials
Read More
Read More
2022/01/27
2021 Business Update
Read More
Read More
2022/01/17
Future of TAVR for AR JenaValve Trilogy
TM
TAVR System
Read More
Read More
2021/11/19
Introduction of TaurusWave
®
Lithotripsy Valvuloplasty System and FIM Clinical Trial
Read More
Read More
2021/08/31
Peijia Medical 2021 Interim Results Presentation
Read More
Read More
2021/07/02
TAVR Commercialization Management Update
Read More
Read More
2021/04/29
Peijia Medical TAVR Guidance Update Call Presentation
Read More
Read More
2021/03/29
Peijia 2020 Annual Results Company Presentation
Read More
Read More
2020/08/28
Peijia Medical 2020 Interim Results Presentation
Read More
Read More
